Correction: METTL16 promotes glycolytic metabolism reprogramming and colorectal cancer progression

J Exp Clin Cancer Res. 2024 Jan 22;43(1):26. doi: 10.1186/s13046-024-02951-x.

Wei Wei^{1

2}, Zhong-Yuan Zhang³, Bin Shi⁴, Yike Cai⁵, Hou-Shun Zhang⁶, Chun-Lei Sun⁴, Yun-Fei Fei^{1

2}, Wen Zhong⁶, Shuang Zhang^{1

2}, Chen Wang^{1

2}, Bing He^{1

2}, Guan-Min Jiang⁷, Hao Wang^{8

9}

¹ Department of Laboratory Medicine, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China.
² Core Unit of National Clinical Research Center for Laboratory Medicine, Hefei, China.
³ Department of Radiology, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China.
⁴ Department of General Surgery, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China.
⁵ Center for Certification and Evaluation, Guangdong Drug Administration, Guangzhou, China.
⁶ Department of Pathology, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China.
⁷ Department of Clinical Laboratory, The Fifth Affiliated Hospital, Sun Yat-sen University, Zhuhai, China. [email protected].
⁸ Department of Laboratory Medicine, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China. [email protected].
⁹ Core Unit of National Clinical Research Center for Laboratory Medicine, Hefei, China. [email protected].

No abstract available

Publication types